PATENT CLAIM ANALYSIS

Application Number: 16151450
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-01
Patent Classification: ["424", "204100"]

Abstract:
The present invention relates to modified, live Porcine Reproductive and Respiratory Syndrome viruses. Viruses were genetically analyzed and selected based on phylogenetic grouping for modification by repeated passage in tissue culture. The modified, live viruses were assessed for the ability to provide protective immunity to heterologous viruses. The modified, live viruses are useful in vaccines, particularly in vaccines which can treat infection of swine by multiple heterologous viruses.

Claim (Index 10):
A method of treating or preventing a symptom caused by type 2 Porcine Reproductive and Respiratory Syndrome (PRRS) in a porcine animal, comprising administering to said porcine animal an immunogenic composition comprising a modified, live PRRS virus strain having a consensus complementary DNA sequence at least 98% identical to a sequence selected from the group of SEQ ID NO: 4, SEQ ID NO: 10, and SEQ ID NO: 11; and\n a pharmaceutically-acceptable excipient, stabilizer, solubilizer, or diluent.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 97.0
- Lexical Diversity: 1.52
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15429206', '15801754', '15358288', '15413843', '13895564']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.752079209126926
- 35 USC 102 Novelty (BERT): 0.6519809028192776
- Combined Prediction Score: 0.7420693784961613
- Mean Citation Score: 413.67829
- Max Citation Score: 631.2444
- Similarity Product: 612.0906664950371

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test